543828 — Sudarshan Pharma Industries Balance Sheet
0.000.00%
- IN₹6.81bn
- IN₹8.50bn
- IN₹5.05bn
- 55
- 24
- 61
- 44
Annual balance sheet for Sudarshan Pharma Industries, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | PRESS |
Standards: | IAS | IAS | IAS | IAS | — |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 12.5 | 2.36 | 117 | 16.4 | 20.5 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 604 | 735 | 815 | 1,225 | 1,648 |
Total Inventory | |||||
Total Other Current Assets | |||||
Total Current Assets | 876 | 1,296 | 1,986 | 2,416 | 3,348 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 59.8 | 68.8 | 190 | 224 | 261 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 993 | 1,375 | 2,325 | 2,831 | 4,024 |
Accounts Payable | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 712 | 1,010 | 1,185 | 1,608 | 2,597 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 768 | 1,077 | 1,315 | 1,714 | 2,709 |
Common Stock | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 225 | 298 | 1,010 | 1,117 | 1,315 |
Total Liabilities & Shareholders' Equity | 993 | 1,375 | 2,325 | 2,831 | 4,024 |
Total Common Shares Outstanding |